Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Milestone Pharmaceuticals Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 47 | 56 | +9 |
| Shares | 22.0M | 24.2M | +2.19M (+10.0%) |
| Value | $198.7M | $96.9M | −$101.8M (−51.2%) |
New holders (24)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (15)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Ra Capital Management, L.P. | 2,246,503 | $20.6M |
| Novo Holdings A/S | 2,000,000 | $18.4M |
| Great Point Partners LLC | 674,656 | $6.20M |
| Paradigm Biocapital Advisors LP | 634,211 | $5.83M |
| Acuta Capital Partners, LLC | 597,026 | $5.49M |
| Janus Henderson Group PLC | 560,168 | $5.14M |
| Eversept Partners, LP | 126,826 | $1.17M |
| Ensign Peak Advisors, Inc | 69,422 | $638.0K |
| Susquehanna International Group, LLP | 46,308 | $426.0K |
| Fred Alger Management, LLC | 26,672 | $245.0K |
| Caption Management, LLC | 25,378 | $233.0K |
| Engineers Gate Manager LP | 11,800 | $108.0K |
| Susquehanna Fundamental Investments, LLC | 11,499 | $106.0K |
| Cowen and Company, LLC | 14,000 | $20.0K |
| CSS LLC | 1,008 | $9.00K |